CD44V (v8-v10) encompassed v9 which included binding region with cystine transporter xCT to regulate redox status through membrane xCT and promote tumor growth [11], supporting importance of cysteine metabolism in cancer initiation capacity representing cancer stemness [12]. The gene discussed is SLC7A11; the disease is cancer.